Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
30
Number of overlapping holdings
52.6%
% of HELX's 68 holdings also in WDNA
33.7%
% of WDNA's 91 holdings also in HELX
Overlap by Weight
Sector Drift (HELX minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HELX |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 4.2% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 4.8% | 1.3% | 1.3% |
|
DANAHER CORP | 5.4% | 1.3% | 1.3% |
|
IONIS PHARMACEUTICALS, INC. | 2.7% | 1.2% | 1.2% |
|
REGENERON PHARMACEUTICALS | 4.6% | 1.2% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
HELX Overweight Relative to WDNA
|
MEDPACE HOLDINGS, INC. | 8.0% |
|
THERMO FISHER SCIENTIFIC INC | 5.1% |
|
DANAHER CORP | 4.2% |
|
KRYSTAL BIOTECH, INC. | 3.7% |
|
VERTEX PHARMACEUTICALS INC | 3.5% |
|
REGENERON PHARMACEUTICALS | 3.4% |
|
BRUKER CORP | 3.2% |
 |
SARTORIUS AG PREF | 3.1% |
 |
SAMSUNG BIOLOGICS CO., LTD. | 2.9% |
|
CHARLES RIVER LABORATORIES | 2.6% |
HELX Underweight Relative to WDNA
|
IOVANCE BIOTHERAPEUTICS INC | -3.9% |
|
FATE THERAPEUTICS INC | -3.1% |
|
TWIST BIOSCIENCE CORP. | -2.9% |
 |
NOVOZYMES A/S-B SHARES | -2.4% |
|
BLUEPRINT MEDICINES CORP. | -2.2% |
|
BRIDGEBIO PHARMA, INC. | -2.0% |
 |
ALCOBRA LTD | -1.7% |
|
VERICEL CORPORATION | -1.7% |
|
AGIOS PHARMACEUTICALS INC | -1.6% |
|
CARIBOU BIOSCIENCES, INC. | -1.6% |